Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward

D Barnett1, V Granger, L Whitby

  • 1UK NEQAS for Leucocyte Immunophenotyping, Department of Haematology, Royal Hallamshire Hospital, Sheffield. d.barnett@sheffield.ac.uk

Summary

Single-platform technology offers improved accuracy for enumerating CD4+ T lymphocytes and CD34+ stem cells. This method demonstrates lower inter-laboratory coefficients of variation (CVs) compared to dual-platform methods, enhancing quality control in clinical trials.